See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Sudeep Shivakumar

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	42058833	0	Mai V, Martens ESL, Righini M, et al. Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism. Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
	41812192	0	Castellucci LA, Chen VM, Kovacs MJ, et al. Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703.
	41341669	0	Robin A, Liwski D, Shivakumar S, et al. Impact of Provincial Pharmacare Coverage for Direct Oral Anticoagulants on Long-Term Anticoagulation for Unprovoked Venous Thromboembolism. Can J Hosp Pharm. 2025 Dec 10;78(4):e3688. doi: 10.4212/cjhp.3688. eCollection 2025.
	41211763	0	Wang TF, Yeo E, Gross PL, et al. A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study. Am J Hematol. 2025 Nov 10. doi: 10.1002/ajh.70127.
	41065579	0	Delluc A, Carrier M, Lauw M, et al. Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey. Blood Coagul Fibrinolysis. 2025 Oct 6. doi: 10.1097/MBC.0000000000001388.
	40680941	0	Sharma S, Soon L, de Wit K, et al. Validation of the ToDay, a Simplified Diagnostic Algorithm for Deep Vein Thrombosis. J Thromb Haemost. 2025 Jul 16:S1538-7836(25)00418-0. doi: 10.1016/j.jtha.2025.06.029.
	40578691	0	Mai V, Martens ESL, Righini M, et al. Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
	38262288	0	Abdulrehman J, Harrigan A, Simard C, et al. TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey. Thromb Res. 2024 Jan 17;235:11-14. doi: 10.1016/j.thromres.2024.01.009.
	37722206	0	Tathireddy H, Rice D, Martens K, et al. Breaking down tumor thrombus: Current strategies for medical management. Thromb Res. 2023 Sep 13;230:144-151. doi: 10.1016/j.thromres.2023.09.004.
	37121015	0	Potere N, Di Nisio M, Porreca E, et al. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36315952	0	Shivakumar S. In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed. Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0089.
	36135074	0	Harrigan AM, Rioux J, Shivakumar S. Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner. Curr Oncol. 2022 Sep 8;29(9):6419-6432. doi: 10.3390/curroncol29090505.
	35660801	0	Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014.
	35587536	0	Popov J, Coelho S, Carrier M, et al. Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study. J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	34940092	0	Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453.
	34807722	0	Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34518263	0	Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557.
	32346486	0	Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1. eCollection 2020.
	32211571	0	Kahn SR, Shivakumar S. What's new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost. 2020 Mar 9;4(3):366-376. doi: 10.1002/rth2.12323. eCollection 2020 Mar.
	31380891	0	Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.
	30511879	0	Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
	29353682	0	van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.
	29310057	0	Skeith L, Carrier M, Shivakumar S, et al. Guiding curriculum development of a national research training program in thrombosis medicine: A needs assessment involving faculty and trainees. Thromb Res. 2018 Feb;162:79-86. doi: 10.1016/j.thromres.2017.12.008. Epub 2017 Dec 13.
	29212129	0	Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6.
	28680172	0	Al Saleh AS, Berrigan P, Anderson D, et al. Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation. Can J Hosp Pharm. 2017 May-Jun;70(3):188-199. doi: 10.4212/cjhp.v70i3.1658. Epub 2017 Jun 30.
	28160670	0	Coyle K, Carrier M, Lazo-Langner A, et al. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism. Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.
	27031923	0	Gauthier K, Le Gal G, Shivakumar S, et al. Inter-observer reliability of the HERDOO2 clinical decision rule. Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15.
	26817957	0	Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27.
	26095467	0	Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.
	25966905	0	Schulman S, Carrier M, Lee AY, et al. Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation. 2015 Jul 21;132(3):167-73. doi: 10.1161/CIRCULATIONAHA.115.015688. Epub 2015 May 12.